i represent marketing failure: i have azd monoclonal antibodies 3rd research trial azd7442 , followed 6 mo later by standard covid pfizer 2-dose, 3rd primary pfizer 2 mos later immuno benefit. my booster - likely pfizer - follows 6 mos barring protocol updates .